Slingshot members are tracking this event:

Agios (AGIO) to Present Data on Expansion Phase 1 Study of AG-120 in Advanced 1DH1 Mutant Positive Low-Grade Glioma in the Second Half of 2016

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 18, 2016
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Expansion Phase, Phase 1, Ag-120, Advanced Idh1 Mutant Positive Low-grade, Glioma, Data Release